Corning Incorporated (NYSE: GLW) today announced two additions to its 3D cell culture portfolio that provide new solutions to support spheroid and organoid culture models.
Elplasia®, a 3D cell culture microplate, features a microcavity technology that enables high volume spheroid formation, culture, and analysis.
A new Matrigel® matrix for organoid culture is optimized to support organoid growth and differentiation.
These portfolio expansions are designed to meet industry growth and demand trends for technology capable of producing high densities of spheroids, as well as generation of complex organoids for drug discovery, cancer research, and other disease modeling applications.
“Corning’s newest 3D cell culture tools are addressing the growing complexity of 3D research and the need to scale spheroid and organoid production for applications across the industry. This includes drug screening, cancer and tumor biology, stem cell biology, cell therapy research, and 3D tissue engineering,” said Keith Olson, vice president of Business Operations and Technology at Corning Life Sciences. “These tools will allow for uniform and highly reproducible formation of organoids and spheroids at the volumes essential to further research in these critical areas.”
Elplasia plate technology was recently acquired by Corning Life Sciences and has been integrated into Corning’s 3D multicellular spheroid product offering. Corning Elplasia plates feature novel well geometries that promote uniform spheroid formation and are available in two surface coatings – Corning Ultra Low Attachment (ULA) surface on round bottom plates and plasma treated (for self-coating) on square bottom plates.
Matrigel matrix for organoid culture is an optimized extracellular matrix that provides a convenient, ready-to-use solution, verified to support organoid growth and differentiation. Each lot has been qualified to form stable “3D dome” structures and provides the matrix stiffness required to support a successful organoid workflow.
Demand for both organoids and spheroids continues to increase with advances in research and technology in 3D cell culture. With the effectiveness of 3D spheroids in many areas of research, including anti-cancer drug screening and in vitro tumor studies, the need for better methods to produce and replicate spheroids of uniform size in mass quantities has emerged. Similarly, organoids have become increasingly popular in disease modeling and drug discovery, as they resemble the composition and functionality of organs.
To learn more about Corning Life Sciences products, please contact a customer service representative at 1-800-492-1110, toll free in the United States; (+1) 1-978-442-2200 internationally; or visit http://zhongliu0391.com/lifesciences.
Caution Concerning Forward-Looking Statements
This press release contains “forward-looking statements” (within the meaning of the Private Securities Litigation Reform Act of 1995), which are based on current expectations and assumptions about Corning’s financial results and business operations, that involve substantial risks and uncertainties that could cause actual results to differ materially。 These risks and uncertainties include: the effects of acquisitions, dispositions and other similar transactions by the Company, the effect of global business, financial, economic and political conditions; tariffs and import duties; currency fluctuations between the U。S。 dollar and other currencies, primarily the Japanese yen, New Taiwan dollar, euro, Chinese yuan, and South Korean won; product demand and industry capacity; competitive products and pricing; availability and costs of critical components and materials; new product development and commercialization; order activity and demand from major customers; the amount and timing of our cash flows and earnings and other conditions, which may affect our ability to pay our quarterly dividend at the planned level or to repurchase shares at planned levels; possible disruption in commercial activities due to terrorist activity, cyber-attack, armed conflict, political or financial instability, natural disasters, or major health concerns; unanticipated disruption to equipment, facilities, IT systems or operations; effect of regulatory and legal developments; ability to pace capital spending to anticipated levels of customer demand; rate of technology change; ability to enforce patents and protect intellectual property and trade secrets; adverse litigation; product and components performance issues; retention of key personnel; customer ability, most notably in the Display Technologies segment, to maintain profitable operations and obtain financing to fund their ongoing operations and manufacturing expansions and pay their receivables when due; loss of significant customers; changes in tax laws and regulations including the Tax Cuts and Jobs Act of 2017; and the potential impact of legislation, government regulations, and other government action and investigations。
For a complete listing of risks and other factors, please reference the risk factors and forward-looking statements described in our annual reports on Form 10-K and quarterly reports on Form 10-Q. Forward-looking statements speak only as of the day that they are made, and Corning undertakes no obligation to update them in light of new information or future events.
In accordance with guidance provided by the SEC regarding the use of company websites and social media channels to disclose material information, Corning Incorporated (“Corning”) wishes to notify investors, media, and other interested parties that it uses its website (http://zhongliu0391.com/worldwide/en/about-us/news-events.html) to publish important information about the company, including information that may be deemed material to investors, or supplemental to information contained in this or other press releases. The list of websites and social media channels that the company uses may be updated on Corning’s media and website from time to time. Corning encourages investors, media, and other interested parties to review the information Corning may publish through its website and social media channels as described above, in addition to the company’s SEC filings, press releases, conference calls, and webcasts.
About Corning Incorporated
Corning (zhongliu0391.com) is one of the world's leading innovators in materials science, with a more than 165-year track record of life-changing inventions. Corning applies its unparalleled expertise in glass science, ceramic science, and optical physics along with its deep manufacturing and engineering capabilities to develop category-defining products that transform industries and enhance people's lives. Corning succeeds through sustained investment in RD&E, a unique combination of material and process innovation, and deep, trust-based relationships with customers who are global leaders in their industries.
幸运飞艇官网开奖app下载Corning's capabilities are versatile and synergistic, which allows the company to evolve to meet changing market needs, while also helping our customers capture new opportunities in dynamic industries. Today, Corning's markets include optical communications, mobile consumer electronics, display technology, automotive, and life sciences vessels. Corning's industry-leading products include damage-resistant cover glass for mobile devices; precision glass for advanced displays; optical fiber, wireless technologies, and connectivity solutions for state-of-the-art communications networks; trusted products to accelerate drug discovery and delivery; and clean-air technologies for cars and trucks.